Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Shasun And Strides Agree To Combine

by Jean-François Tremblay
October 6, 2014 | A version of this story appeared in Volume 92, Issue 40

Two medium-sized Indian pharmaceutical companies, Strides Arcolab and Shasun Pharmaceuticals, will merge to create an entity with annual sales of about $615 million. With headquarters in Chennai on the southeast coast of India, Shasun is a producer of generic formulations and active pharmaceutical ingredients that also provides contract research and manufacturing services. The firm employs 1,800. Strides, also a producer of generics, has headquarters in Bangalore and employs more than 1,500 people.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.